Company / Operating Cash Flow per Share
Bio-Rad Laboratories Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$18.22
FY2025
5-year range
$6.45 / $22.18
FY2021-FY2025
Trend
+19.2%
vs FY2024
Sector context
#15 of 161
Health Care
What the data says
Among 161 Health Care companies, Bio-Rad Laboratories is in the top 9% for operating cash flow per share. Operating Cash Flow per Share has increased for 3 consecutive years, from $6.45 in FY2022 to $18.22 in FY2025.
Based on SEC 10-K filings.
18.22 in FY2025 with a 5-year CAGR of +14.0%. Top quartile in the Health Care sector.
Improved from $12.41 to $18.22 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +41.4%
- 5-Year CAGR
- +14.0%
- 10-Year CAGR
- -
Sector benchmark
+174.3% above sector average
Key checks
Key Insights
- Bio-Rad Laboratories's operating cash flow per share has grown for 3 consecutive years.
- In FY2025, operating cash flow per share increased 19.2% year-over-year.
- Ranks #15 out of 161 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2021.
Company context
Key Data Points
- Strong return on equity: 23.0%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $18.22 | +19.2% |
| FY2024 | $15.28 | +23.1% |
| FY2023 | $12.41 | +92.5% |
| FY2022 | $6.45 | -70.9% |
| FY2021 | $22.18 | +134.8% |
| FY2020 | $9.44 | -38.1% |
| FY2019 | $15.25 | +109.2% |
| FY2018 | $7.29 | +15.1% |
| FY2017 | $6.33 | -32.5% |
| FY2016 | $9.38 | +45.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026